Human SH2B1 mutations are associated with maladaptive behaviors and obesity

Michael E. Doche(University of Michigan–Ann Arbor), Elena G. Bochukova(University of Cambridge), Hsiao-Wen Su(University of Michigan–Ann Arbor), Laura R. Pearce(University of Cambridge), Julia M. Keogh(University of Cambridge), Elana Henning(University of Cambridge), Joel M. Cline(University of Michigan–Ann Arbor), Anne Dale(Queen Elizabeth Hospital), Tim Cheetham(Royal Victoria Infirmary), Inês Barroso(Wellcome Sanger Institute), Lawrence S. Argetsinger(Laboratoire d’immunologie intégrative du cancer), Stephen O’Rahilly(University of Cambridge), Liangyou Rui, Christin Carter‐Su(Diabetes Australia), I. Sadaf Farooqi(University of Cambridge)
Journal of Clinical Investigation
November 19, 2012
Cited by 197

Abstract

Src homology 2 B adapter protein 1 (SH2B1) modulates signaling by a variety of ligands that bind to receptor tyrosine kinases or JAK-associated cytokine receptors, including leptin, insulin, growth hormone (GH), and nerve growth factor (NGF). Targeted deletion of Sh2b1 in mice results in increased food intake, obesity, and insulin resistance, with an intermediate phenotype seen in heterozygous null mice on a high-fat diet. We identified SH2B1 loss-of-function mutations in a large cohort of patients with severe early-onset obesity. Mutation carriers exhibited hyperphagia, childhood-onset obesity, disproportionate insulin resistance, and reduced final height as adults. Unexpectedly, mutation carriers exhibited a spectrum of behavioral abnormalities that were not reported in controls, including social isolation and aggression. We conclude that SH2B1 plays a critical role in the control of human food intake and body weight and is implicated in maladaptive human behavior.


Related Papers

No related papers found

Powered by citation graph analysis